BDNF Val66Met 预测阿尔茨海默病预防登记队列的认知下降
与 Val/Val 纯合子相比,Met 携带者言语学习和记忆及速度与灵活性下降更陡;淀粉样蛋白负荷加重了 Met 携带者的言语学习和记忆下降。
要点
- BDNF Met 等位基因与言语学习和记忆及速度与灵活性下降更快相关。
- 淀粉样蛋白负荷加重 Met 携带者的言语学习和记忆下降。
- BDNF Val66Met 可能是阿尔茨海默病治疗的新靶点。
核心结论
- 在具有阿尔茨海默病风险的中年队列中,BDNF Met 等位基因携带与情景记忆和执行功能下降更陡相关,且淀粉样蛋白负荷加重此下降。
研究设计与样本
- 其中 140 人接受 11C-Pittsburgh 化合物 B 扫描,采用协变量调整混合效应回归模型分析。
主要发现
- 与 BDNF Val/Val 纯合子相比,Met 携带者言语学习和记忆下降更陡(p=0.002),速度与灵活性下降更陡(p=0.017)。
- 淀粉样蛋白负荷调节 BDNF 与言语学习和记忆的关系,淀粉样蛋白负荷更大的 Met 携带者认知下降更陡(p=0.033)。
临床怎么用
- BDNF Val66Met 基因分型或有助于识别认知下降风险更高的中年个体。
- BDNF Val66Met 可作为新型阿尔茨海默病治疗靶点考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the influence of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism on longitudinal cognitive trajectories in a large, cognitively healthy cohort enriched for Alzheimer disease (AD) risk and to understand whether β-amyloid (Aβ) burden plays a moderating role in this relationship. METHODS: One thousand twenty-three adults (baseline age 54.94 ± 6.41 years) enrolled in the Wisconsin Registry for Alzheimer's Prevention underwent BDNF genotyping and cognitive assessment at up to 5 time points (average follow-up 6.92 ± 3.22 years). A subset (n = 140) underwent 11C-Pittsburgh compound B (PiB) scanning. Covariate-adjusted mixed-effects regression models were used to elucidate the effect of BDNF on cognitive trajectories in 4 cognitive domains, including verbal learning and memory, speed and flexibility, working memory, and immediate memory. Secondary mixed-effects regression models were conducted to examine whether Aβ burden, indexed by composite PiB load, modified any observed BDNF-related cognitive trajectories. RESULTS: Compared to BDNF Val/Val homozygotes, Met carriers showed steeper decline in verbal learning and memory (p = 0.002) and speed and flexibility (p = 0.017). In addition, Aβ burden moderated the relationship between BDNF and verbal learning and memory such that Met carriers with greater Aβ burden showed even steeper cognitive decline (p = 0.033). CONCLUSIONS: In a middle-aged cohort with AD risk, carriage of the BDNF Met allele was associated with steeper decline in episodic memory and executive function. This decline was exacerbated by greater Aβ burden. These results suggest that the BDNF Val66Met polymorphism may play an important role in cognitive decline and could be considered as a target for novel AD therapeutics.
引用
- Boots EA, Schultz SA, Clark LR, et al. BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention. Neurology. 2017. PMID: 28468845. doi:10.1212/WNL.0000000000003980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。